González RV, Rosas SVM, Ornelas OLA, Sánchez CX, López LJM

Language: Spanish
References: 11
Page: 68-72
PDF size: 197.39 Kb.

ABSTRACT

Introduction: Achalasia is an uncommon but important disease that is the best understood and most readily treatable esophageal motility disorder. It serves as a prototype for disorders of the enteric nervous system and is characterized by degeneration of the myenteric neurons that innervate the lower esophageal sphincter and esophageal body. Among the treatment options, the one that has proven most effective is minimally invasive surgery, with excellent results obtained. Objective: To report the results of the employment of the laparoscopic approach for the realization of Heller myotomy associated with Dor antireflux procedure by esophageal calibration with catheter Levin in the General Hospital of Mexico. Design: Clinical, descriptive, transverse, retrospective and observational. Setting: Hospital of the third level of attention. Material and methods: We analyzed all Heller myotomies in which esophageal calibration was performed by Levin catheter, from March 1st, 2007 to February 28, 2012. Results: 22 were performed in women (78.57%) and 6 in men (21.43%). Using this calibration technique we reported no incidents or complications, there was only one major complication, esophageal perforation, which was noticed and repaired in a single procedure. The average hospital stay was three days. There were no major complications associated with the esophageal calibration procedure. Conclusions: The best therapeutic option for the treatment of achalasia is the Heller myotomy associated with an antireflux procedure, the use of Levin catheters for esophageal calibration is safe and economical, not associated with a greater number of complications and similar in final results to intraoperative endoscopy.

REFERENCES

1. Walzer N, Hirano I. Achalasia. Gastroenterol Clin North Am. 2008; 37(4): 807-825.

2. Williams VA, Peters JH. Achalasia of the esophagus: a surgical disease. J Am Coll Surg. 2009; 208: 151-162.

3. Ghoshal UC, Daschakraborty SB, Singh R. Pathogenesis of achalasia cardia. World J Gastroenterol. 2012; 18(24): 3050-3057.

4. Chuah SK, Hsu PI, Wu KL, Wu DC, Tai WC, Changchien CS. 2011 update on esophageal achalasia. World J Gastroenterol. 2012; 18(14): 1573-1578.

5. Katada N, Sakuramoto S, Yamashita K, Shibata T, Moriya H, Kikuchi S, Watanabe M. Recent trends in the management of achalasia. Ann Thorac Cardiovasc Surg. 2012; 18: 420-428.

6. Gockel I, Sgourakis G, Drescher DG, Lang H. Impact of minimally invasive surgery in the spectrum of current achalasia treatment options. Scand J Surg. 2011; 100(2): 72-77.

7. Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M, Cuttitta A, Elizalde JI et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011; 364: 1807-1816.

8. Hughes MJ, Chowdhry MF, Walker WS. Can thoracoscopic Heller’s myotomy give equivalent results to the more usual laparoscopic Heller’s myotomy in the treatment of achalasia? Interact Cardiovasc Thorac Surg. 2011; 13(1): 77-81. Epub 2011 Apr 15.

9. Farrokhi F, Vaezi MF. Idiopathic (primary) achalasia. Orphanet Journal of Rare Diseases. 2007; 2:38.

10. Richards WO, Torquati A, Holzman MD, Khaitan L, Byrne D, Lutfi R, Sharp KW. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia. A prospective randomized double-blind clinical trial. Ann Surg. 2004; 240: 405-415.

11. Litle VR. Laparoscopic Heller myotomy for achalasia: a review of the controversies. Ann Thorac Surg. 2008; 85: S743-S746.